Corcept Therapeutics
Trade Corcept Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About CORT
Corcept Therapeutics, Inc. engages in the business of discovering and developing pharmaceutical products and medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol. The company was founded by David B.
CORT Key Statistics
Stock Snapshot
As of today, Corcept Therapeutics(CORT) shares are valued at $108.55. The company's market cap stands at 11.96B, with a P/E ratio of 269.41.
As of 2026-08-08, Corcept Therapeutics(CORT) stock has fluctuated between $108.08 and $110.79. The current price stands at $108.55, placing the stock +0.4% above today's low and -2.0% off the high.
Corcept Therapeutics(CORT) shares are trading with a volume of 737.33K, against a daily average of 1.55M.
During the past year, Corcept Therapeutics(CORT) stock moved between $28.66 at its lowest and $122.21 at its peak.
During the past year, Corcept Therapeutics(CORT) stock moved between $28.66 at its lowest and $122.21 at its peak.
CORT News
Advertisement Why Corcept Therapeutics stock is back in focus after Q2 earnings Corcept Therapeutics (CORT) is drawing fresh attention after its July 29 earni...
Corcept Therapeutics stock has delivered a very large 5 year return, yet its recent valuation checks suggest the shares are not an obvious bargain at today's le...
Following the release of a lackluster earnings report from Corcept Therapeutics Incorporated ( ) the stock price made a strong positive move. Our analysis sugge...
Analyst ratings
83%
of 6 ratingsMore CORT News
In late July 2026, Corcept Therapeutics reported second-quarter net income of US$42.99 million, up from US$35.15 million a year earlier, with diluted earnings p...
With inflation trends diverging across regions and central banks keeping policy options open, it makes sense to focus on companies where growth and insider conf...
Founder-led companies sit at an interesting crossroad right now. Inflation, central bank moves and energy prices are pulling markets in different directions, wh...
Global markets feel pulled between firm inflation, shifting central bank signals and uneven growth data. Bond yields in the US, UK and Europe keep pressure on v...
Founder led companies can offer something many investors value in markets shaped by inflation questions, interest rate uncertainty and uneven growth data. These...
With central banks weighing their next moves, inflation signals pulling in different directions and energy prices feeding through to consumer bills, many invest...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.